• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[原发性醛固酮增多症患者术后持续性高血压的危险因素]

[Risk factors of persistent hypertension in primary aldosteronism patients after surgery].

作者信息

Huang-Fu Y C, DU Y Q, Yu L P, Xu T

机构信息

Department of Urology, Peking University People' s Hospital, Beijing 100044, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Aug 18;54(4):686-691. doi: 10.19723/j.issn.1671-167X.2022.04.017.

DOI:10.19723/j.issn.1671-167X.2022.04.017
PMID:35950393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9385504/
Abstract

OBJECTIVE

To analyze the risk factors of persistent hypertension in patients who underwent adrenalectomy for primary aldosteronism and to evaluate the predictive value of the aldosteronoma resolution score (ARS) scoring system for surgical outcomes of adrenalectomy for primary aldosteronism.

METHODS

We reviewed the clinical characteristics of patients who underwent adrenalectomy for primary aldosteronism from 2018 to 2021 at Peking University People' s Hospital to recognize risk factors of uncured hypertension after surgery. Based on the patient' s clinical outcomes, the patients were divided into complete success group and partial/absent success group. Risk factors for persistent hypertension were analyzed. The value of the ARS scoring system was assessed by the area under the curve ().

RESULTS

In this study, 112 patients were included. Most of the patients benefited from the surgery for 94.6% were a complete or partial clinical success after follow-up for at least 6 months. According to postoperative hypertension status, the patients were divided into complete success group (51 cases) and partial/absent success group (61 cases). There were statistical differences between the two groups in age, body mass index (BMI), waist circumference, duration of hypertension, number of preoperative antihypertension medications, preoperative systolic blood pressure, history of diabetes, history of cardiovascular and cerebrovascular diseases, serum creatinine, estimated glomerular filtration rate(eGFR), high-density lipoprotein cholesterol and triglyceride. Logistic regression analysis showed that age (=1.111, 95%: 1.029-1.199), waist circumference (=1.073, 95% 1.013-1.137), pre-operative systolic blood pressure (=1.033, 95%: 1.008-1.060) and history of cardiovascular and cerebrovascular diseases (=16.061, 95%: 1.312-196.612) were the risk factors for uncured hypertension in primary aldosteronism patients after surgery, but female gender not. The median ARS in the complete success group was 4 and in the partial/absent success group, it was 2. Among the patients with ARS of 4-5, the cure rate of hypertension was 76.5%. The area under the curve of ARS was 0.743.

CONCLUSION

The history of cardiovascular and cerebrovascular diseases is a significant risk factor for persistent hypertension after surgery in primary aldosteronism patients. ARS scoring system has a certain value in predicting the postoperative hypertension status of primary aldosteronism patients. However, further research is still needed on a prediction model for surgical outcomes of primary aldosteronism which is more suitable for the Chinese population is still needed.

摘要

目的

分析原发性醛固酮增多症患者行肾上腺切除术后持续性高血压的危险因素,并评估醛固酮瘤消退评分(ARS)系统对原发性醛固酮增多症肾上腺切除术手术结局的预测价值。

方法

回顾2018年至2021年在北京大学人民医院行肾上腺切除术治疗原发性醛固酮增多症患者的临床特征,以识别术后高血压未治愈的危险因素。根据患者的临床结局,将患者分为完全成功组和部分/无成功组。分析持续性高血压的危险因素。通过曲线下面积()评估ARS评分系统的价值。

结果

本研究共纳入112例患者。大多数患者从手术中获益,94.6%的患者在至少随访6个月后获得完全或部分临床成功。根据术后高血压状态,将患者分为完全成功组(51例)和部分/无成功组(61例)。两组在年龄、体重指数(BMI)、腰围、高血压病程、术前抗高血压药物数量、术前收缩压、糖尿病史、心脑血管疾病史、血清肌酐、估算肾小球滤过率(eGFR)、高密度脂蛋白胆固醇和甘油三酯方面存在统计学差异。Logistic回归分析显示,年龄(=1.111,95%:1.029 - 1.199)、腰围(=1.073,95% 1.013 - 1.137)、术前收缩压(=1.033,95%:1.008 - 1.060)和心脑血管疾病史(=16.061,95%:1.312 - 196.612)是原发性醛固酮增多症患者术后高血压未治愈的危险因素,但女性不是。完全成功组的ARS中位数为4,部分/无成功组为2。在ARS为4 - 5的患者中,高血压治愈率为76.5%。ARS的曲线下面积为0.743。

结论

心脑血管疾病史是原发性醛固酮增多症患者术后持续性高血压的重要危险因素。ARS评分系统在预测原发性醛固酮增多症患者术后高血压状态方面具有一定价值。然而,仍需要进一步研究更适合中国人群的原发性醛固酮增多症手术结局预测模型。

相似文献

1
[Risk factors of persistent hypertension in primary aldosteronism patients after surgery].[原发性醛固酮增多症患者术后持续性高血压的危险因素]
Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Aug 18;54(4):686-691. doi: 10.19723/j.issn.1671-167X.2022.04.017.
2
Predictors of successful outcome after adrenalectomy for unilateral primary aldosteronism.单侧原发性醛固酮增多症肾上腺切除术成功的预测因素。
Front Endocrinol (Lausanne). 2023 Aug 11;14:1205988. doi: 10.3389/fendo.2023.1205988. eCollection 2023.
3
Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.原发性醛固酮增多症患者腹腔镜肾上腺切除术后主动脉钙化对持续性高血压的影响。
Int J Urol. 2016 May;23(5):412-7. doi: 10.1111/iju.13060. Epub 2016 Feb 2.
4
Validation of the Aldosteronoma Resolution Score as a Predictive Resolution Score of Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism in a North-African Population.醛固酮瘤缓解评分作为北非人群原发性醛固酮增多症单侧肾上腺切除术后高血压缓解的预测评分的验证。
World J Surg. 2023 Nov;47(11):2776-2783. doi: 10.1007/s00268-023-07155-6. Epub 2023 Sep 4.
5
Predicting factors related with uncured hypertension after retroperitoneal laparoscopic adrenalectomy for unilateral primary aldosteronism.单侧原发性醛固酮增多症后腹膜腹腔镜肾上腺切除术后未治愈高血压的相关预测因素。
Medicine (Baltimore). 2019 Jul;98(30):e16611. doi: 10.1097/MD.0000000000016611.
6
Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort.在一个大型队列中,预测原发性醛固酮增多症患者行腹腔镜肾上腺切除术后临床改善和治愈的特征。
Am J Surg. 2015 Oct;210(4):702-9. doi: 10.1016/j.amjsurg.2015.05.033. Epub 2015 Aug 17.
7
Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism.单侧肾上腺切除术治疗原发性醛固酮增多症的临床转归。
JAMA Surg. 2019 Apr 1;154(4):e185842. doi: 10.1001/jamasurg.2018.5842. Epub 2019 Apr 17.
8
Re-evaluating absent clinical success after adrenalectomy in unilateral primary aldosteronism.单侧原发性醛固酮增多症肾上腺切除术后临床疗效缺失的再评估。
Surgery. 2021 Nov;170(5):1389-1396. doi: 10.1016/j.surg.2021.05.038. Epub 2021 Jun 25.
9
Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population.黑人和西班牙裔人群肾上腺切除术的结果和醛固酮瘤缓解评分。
World J Surg. 2021 May;45(5):1475-1482. doi: 10.1007/s00268-021-05967-y. Epub 2021 Feb 7.
10
Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism.开发一种新型列线图以预测原发性醛固酮增多症患者腹腔镜肾上腺切除术后高血压的治愈情况。
World J Surg. 2014 Oct;38(10):2640-4. doi: 10.1007/s00268-014-2612-1.

引用本文的文献

1
Risk factors for persistent hypertension in primary aldosteronism after surgery: a systematic review and meta-analysis.原发性醛固酮增多症术后持续性高血压的危险因素:一项系统评价和荟萃分析。
Front Physiol. 2025 Aug 7;16:1632450. doi: 10.3389/fphys.2025.1632450. eCollection 2025.
2
Clinical and biochemical outcomes after adrenalectomy for primary aldosteronism in tertiary and quaternary referral centers: data from SOPRANO study.原发性醛固酮增多症患者在三级和四级转诊中心行肾上腺切除术的临床和生化结局:SOPRANO 研究的数据。
Hypertens Res. 2024 Mar;47(3):721-734. doi: 10.1038/s41440-023-01554-x. Epub 2024 Jan 5.

本文引用的文献

1
Clinical Score and Machine Learning-Based Model to Predict Diagnosis of Primary Aldosteronism in Arterial Hypertension.基于临床评分和机器学习的模型预测原发性醛固酮增多症在高血压中的诊断。
Hypertension. 2021 Nov;78(5):1595-1604. doi: 10.1161/HYPERTENSIONAHA.121.17444. Epub 2021 Sep 7.
2
Prevalence, Subtype Classification, and Outcomes of Treatment of Primary Aldosteronism: A Prospective Study in China.原发性醛固酮增多症的患病率、亚型分类及治疗结局:中国的一项前瞻性研究。
Endocr Pract. 2021 May;27(5):478-483. doi: 10.1016/j.eprac.2020.10.007. Epub 2020 Dec 14.
3
Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population.黑人和西班牙裔人群肾上腺切除术的结果和醛固酮瘤缓解评分。
World J Surg. 2021 May;45(5):1475-1482. doi: 10.1007/s00268-021-05967-y. Epub 2021 Feb 7.
4
Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism.基于列线图的单侧原发性醛固酮增多症术前评分预测临床转归。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa634.
5
Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.日本全国队列中原发性醛固酮增多症手术后临床成功的预测因素
J Endocr Soc. 2019 Aug 22;3(11):2012-2022. doi: 10.1210/js.2019-00295. eCollection 2019 Nov 1.
6
Association of general and central obesity with hypertension.一般肥胖和中心型肥胖与高血压的关系。
Clin Nutr. 2018 Aug;37(4):1259-1263. doi: 10.1016/j.clnu.2017.05.012. Epub 2017 May 18.
7
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.单侧原发性醛固酮增多症肾上腺切除术的结局:国际共识的结局指标和国际队列缓解率分析。
Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30.
8
Obesity and hypertension.肥胖与高血压。
Pharmacol Res. 2017 Aug;122:1-7. doi: 10.1016/j.phrs.2017.05.013. Epub 2017 May 19.
9
Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients.评估醛固酮消退评分作为法国患者醛固酮瘤肾上腺切除术后高血压预测性消退评分的情况。
Langenbecks Arch Surg. 2017 Mar;402(2):309-314. doi: 10.1007/s00423-017-1557-x. Epub 2017 Jan 22.
10
[A Fisher discriminant model to predict the outcome of postoperative blood pressure in primary aldosteronism].[一种预测原发性醛固酮增多症术后血压结局的Fisher判别模型]
Zhonghua Yi Xue Za Zhi. 2016 Nov 15;96(42):3379-3383. doi: 10.3760/cma.j.issn.0376-2491.2016.42.005.